U.S. Markets closed

Yield10 Bioscience Inc (YTEN) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

Yield10 Bioscience Inc (YTEN) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Yield10 Bioscience Inc, formerly known as Metabolix Inc is an agricultural bioscience company. It is engaged in the development of disruptive technologies to produce the improvements in crop yield for food and feed crops to enhance food security. Yield10 Bioscience Inc has a market cap of $11.450 million; its shares were traded at around $1.14 with and P/S ratio of 20.35. Yield10 Bioscience Inc had annual average EBITDA growth of 54.90% over the past five years.


For the last quarter Yield10 Bioscience Inc reported a revenue of $0.14 million, compared with the revenue of $0.10 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $0.56 million, a decrease of 41.1% from the previous year. For the last five years Yield10 Bioscience Inc had an average revenue decline of 35.7% a year.

The reported loss per diluted share was 92 cents for the year, compared with the loss per share of $28.835 in the previous year. The Yield10 Bioscience Inc had an operating margin of -1667.99%, compared with the operating margin of -983.37% a year before. The 10-year historical median operating margin of Yield10 Bioscience Inc is -970.78%. The profitability rank of the company is 2 (out of 10).

At the end of the fiscal year, Yield10 Bioscience Inc has the cash and cash equivalents of $3.02 million, compared with $14.5 million in the previous year. The company had no long term debt, compared with $1.01 million in the previous year. The interest coverage to the debt is at a comfortable level of 15. Yield10 Bioscience Inc has a financial strength rank of 4 (out of 10).

At the current stock price of $1.14, Yield10 Bioscience Inc is traded at 58.3% premium to its historical median P/S valuation band of $0.72. The P/S ratio of the stock is 20.35, while the historical median P/S ratio is 12.78. The stock lost 39.9% during the past 12 months.

For the complete 20-year historical financial data of YTEN, click here.

This article first appeared on GuruFocus.